The 5-lipoxygenase inhibitor zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis
Y Liu, W Wang, Y Li, Y Xiao, J Cheng… - Biological and …, 2015 - jstage.jst.go.jp
Lipoxygenase (5-LOX) inhibitors have been shown to be protective in several
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
[PDF][PDF] The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis
Y Liu, W Wang, Y Li, Y Xiao, J Cheng, J Jia - Biol. Pharm. Bull, 2015 - scholar.archive.org
5-Lipoxygenase (5-LOX) inhibitors have been shown to be protective in several
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis
Y Liu, W Wang, Y Li, Y Xiao… - Biological & …, 2015 - pubmed.ncbi.nlm.nih.gov
5-Lipoxygenase (5-LOX) inhibitors have been shown to be protective in several
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
[PDF][PDF] The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis
Y Liu, W Wang, Y Li, Y Xiao, J Cheng, J Jia - Biol. Pharm. Bull, 2015 - researchgate.net
5-Lipoxygenase (5-LOX) inhibitors have been shown to be protective in several
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis.
Y Liu, W Wang, Y Li, Y Xiao, J Cheng… - … & Pharmaceutical Bulletin, 2015 - europepmc.org
5-Lipoxygenase (5-LOX) inhibitors have been shown to be protective in several
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis
L Yang, W Wei, L Yuyao, X Yunqi, C Jian… - … & Pharmaceutical Bulletin, 2015 - cir.nii.ac.jp
Lipoxygenase (5-LOX) inhibitors have been shown to be protective in several
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
[HTML][HTML] The 5-Lipoxygenase Inhibitor Zileuton Confers Neuroprotection against Glutamate Oxidative Damage by Inhibiting Ferroptosis
Y Liu, W Wang, Y Li, Y Xiao, J Cheng… - Biological and …, 2015 - jstage.jst.go.jp
Lipoxygenase (5-LOX) inhibitors have been shown to be protective in several
neurodegenerative disease models; however, the underlying mechanisms remain unclear …
neurodegenerative disease models; however, the underlying mechanisms remain unclear …